- Genetic Variation and Survival Analysis of Childhood AML By C-Huanan AML 2015 Protocol in China:Multicenter Clinical Study in 546 CasesFeng, Xiaoqin; Li, Chunfu; Li, Jian; Zheng, Mincui; Liu, Sixi; Yang, Lihua; Jiang, Hua; Xu, Honggui; Wen, Hong; He, Xiangling64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- Gene Mutation and MRD-Directed Risk Stratification Treatment Improves Long Term Survival of the Patients with AML1-ETO-Positive AMLXu, Dan; Yang, Ying; Yin, Zhao; Tu, Sanfang; Nie, Danian; Sun, Qixin; Huang, Zhengqian; Zhang, Yu; Yu, Guopan64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
- Frequency and clinical impact of ETV6/RUNX1, AF4-MLL, and BCR/ABL fusion genes on features of acute lymphoblastic leukemia at presentationAJ, Madu; IC, Ajuba; C, Okocha; OG, Ibegbulam; I, Okpala; OE, NnaNigerian Journal of Clinical Practice, 2016, 19(2): 237.
会议论文
Childhood AML Combined with AML1-ETO Fusion Gene and c-KIT or Other Mutations Had Favorable Survival Treated By the C-Huanan AML 2015 Protocol: Study in Multicenter of South of China
11阅读
